Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)
The Securities Depository Center Co. (Edaa) announced that it deposited today, Feb. 25, the subscribed shares of Middle East Pharmaceutical Industries Co. (Avalon Pharma) into shareholder accounts, according to Tadawul website.
Retail investors started subscribing to 600,000 shares of Avalon Pharma on Jan. 30 at the book-building price of SAR 82 per share, according to data available with Argaam.
The offering was 54.3x covered, and the company allocated a minimum of two shares per substantial subscriber.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}